Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer-Reference-Cited by-同舟云学术

Combination of body mass index and oxidized low density lipoprotein receptor 1 in prognosis prediction of patients with squamous non-small cell lung cancer

Published:2015-05-27 Issue:26 Volume:6 Page:22072-22080
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Jiang Long¹²³⁴,Jiang Shanshan¹,Lin Yongbin¹²³,Yang Han¹²³,Zhao Zerui¹²³,Xie Zehua¹²³,Lin Yaobin¹²³,Long Hao¹²³

Affiliation:

1. Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

2. Lung Cancer Institute of Sun Yat-Sen University, Guangzhou, China

3. Department of Thoracic Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China

4. University of California, San Francisco, San Francisco, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive analysis of the expression and the prognosis for LOX-1 in multiple cancer types;Biotechnology and Genetic Engineering Reviews;2023-04-20

2. Research Progress on the Correlation between LOX-1 and Tumors;Advances in Clinical Medicine;2023

3. The clinical significance of preoperative serum triglyceride, high-density lipoprotein, and low-density lipoprotein levels in lung squamous cell carcinoma;Scientific Reports;2022-10-07

4. Expression of Serum sLOX-1 in Patients with Non-Small-Cell Lung Cancer and Its Correlation with Lipid Metabolism;Canadian Respiratory Journal;2022-04-11

5. LRP6 as a biomarker of poor prognosis of breast cancer;Gland Surgery;2021-08